Davis Polk advised the sole underwriter, Goldman Sachs & Co. LLC, in the offering. SVB Financial Group. completed a $1.25 billion public offering of common stock. The common...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised IDEAYA Biosciences, while Davis Polk advised the underwriters in the offering. IDEAYA Biosciences, Inc. executed its public offering of 5,333,333 shares of common...
You must be a Standard 1 Year member to access this content.
Cooley advised RAPT Therapeutics, while Davis Polk advised the joint book-running managers in the offering. with a $143.7 million SEC-registered follow-on offering of 4,356,060 shares of...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Accuray Incorporated in the deal. Accuray Incorporated executed a private exchange of approximately $82.1 million aggregate principal amount of its outstanding 3.75% convertible...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several purchasers in offering. Ionis Pharmaceuticals, Inc. executed its offering of an aggregate principal amount of $632.5 million of its...
You must be a Standard 1 Year member to access this content.
Davis Polk advised representatives of the underwriters in the offering. Skillz, Inc. executed its $883 million offering of 36,800,000 shares of Class A common stock, which includes...
You must be a Standard 1 Year member to access this content.
